Global Rheumatology Drugs Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

October 2018 | 115 pages | ID: GD32A63DB1CGEN
GlobalInfoResearch

Abstracts

SCOPE OF THE REPORT:

The global Rheumatology Drugs market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Rheumatology Drugs.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Rheumatology Drugs market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Rheumatology Drugs market by product type and applications/end industries.
Market Segment by Companies, this report covers

• Takeda Pharmaceutical
• Sanofi
• Genentech
• Novartis
• Janssen Biotech
• Amgen
• AbbVie
• Pfizer
• Bristol-Myers Squibb Company
• Merck & Co.

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Disease Modifying Anti-rheumatic Drugs
• Nonsteroidal Anti-inflammatory Drugs
• Corticosteroids
• Uric Acid Drugs
• Others

Market Segment by Applications, can be divided into

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Contents

1 RHEUMATOLOGY DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Rheumatology Drugs
1.2 Classification of Rheumatology Drugs by Types
  1.2.1 Global Rheumatology Drugs Revenue Comparison by Types (2017-2023)
  1.2.2 Global Rheumatology Drugs Revenue Market Share by Types in 2017
  1.2.3 Disease Modifying Anti-rheumatic Drugs
  1.2.4 Nonsteroidal Anti-inflammatory Drugs
  1.2.5 Corticosteroids
  1.2.6 Uric Acid Drugs
  1.2.7 Others
1.3 Global Rheumatology Drugs Market by Application
  1.3.1 Global Rheumatology Drugs Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Hospital Pharmacy
  1.3.3 Retail Pharmacy
  1.3.4 Online Pharmacy
1.4 Global Rheumatology Drugs Market by Regions
  1.4.1 Global Rheumatology Drugs Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Rheumatology Drugs Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Rheumatology Drugs Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Rheumatology Drugs Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Rheumatology Drugs Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Rheumatology Drugs Status and Prospect (2013-2023)
1.5 Global Market Size of Rheumatology Drugs (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Takeda Pharmaceutical
  2.1.1 Business Overview
  2.1.2 Rheumatology Drugs Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Takeda Pharmaceutical Rheumatology Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.2 Sanofi
  2.2.1 Business Overview
  2.2.2 Rheumatology Drugs Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Sanofi Rheumatology Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.3 Genentech
  2.3.1 Business Overview
  2.3.2 Rheumatology Drugs Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Genentech Rheumatology Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.4 Novartis
  2.4.1 Business Overview
  2.4.2 Rheumatology Drugs Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Novartis Rheumatology Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.5 Janssen Biotech
  2.5.1 Business Overview
  2.5.2 Rheumatology Drugs Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Janssen Biotech Rheumatology Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.6 Amgen
  2.6.1 Business Overview
  2.6.2 Rheumatology Drugs Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Amgen Rheumatology Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.7 AbbVie
  2.7.1 Business Overview
  2.7.2 Rheumatology Drugs Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 AbbVie Rheumatology Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.8 Pfizer
  2.8.1 Business Overview
  2.8.2 Rheumatology Drugs Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Pfizer Rheumatology Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.9 Bristol-Myers Squibb Company
  2.9.1 Business Overview
  2.9.2 Rheumatology Drugs Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Bristol-Myers Squibb Company Rheumatology Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.10 Merck & Co.
  2.10.1 Business Overview
  2.10.2 Rheumatology Drugs Type and Applications
    2.10.2.1 Product A
    2.10.2.2 Product B
  2.10.3 Merck & Co. Rheumatology Drugs Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL RHEUMATOLOGY DRUGS MARKET COMPETITION, BY PLAYERS

3.1 Global Rheumatology Drugs Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Rheumatology Drugs Players Market Share
  3.2.2 Top 10 Rheumatology Drugs Players Market Share
3.3 Market Competition Trend

4 GLOBAL RHEUMATOLOGY DRUGS MARKET SIZE BY REGIONS

4.1 Global Rheumatology Drugs Revenue and Market Share by Regions
4.2 North America Rheumatology Drugs Revenue and Growth Rate (2013-2018)
4.3 Europe Rheumatology Drugs Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Rheumatology Drugs Revenue and Growth Rate (2013-2018)
4.5 South America Rheumatology Drugs Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Rheumatology Drugs Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA RHEUMATOLOGY DRUGS REVENUE BY COUNTRIES

5.1 North America Rheumatology Drugs Revenue by Countries (2013-2018)
5.2 USA Rheumatology Drugs Revenue and Growth Rate (2013-2018)
5.3 Canada Rheumatology Drugs Revenue and Growth Rate (2013-2018)
5.4 Mexico Rheumatology Drugs Revenue and Growth Rate (2013-2018)

6 EUROPE RHEUMATOLOGY DRUGS REVENUE BY COUNTRIES

6.1 Europe Rheumatology Drugs Revenue by Countries (2013-2018)
6.2 Germany Rheumatology Drugs Revenue and Growth Rate (2013-2018)
6.3 UK Rheumatology Drugs Revenue and Growth Rate (2013-2018)
6.4 France Rheumatology Drugs Revenue and Growth Rate (2013-2018)
6.5 Russia Rheumatology Drugs Revenue and Growth Rate (2013-2018)
6.6 Italy Rheumatology Drugs Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC RHEUMATOLOGY DRUGS REVENUE BY COUNTRIES

7.1 Asia-Pacific Rheumatology Drugs Revenue by Countries (2013-2018)
7.2 China Rheumatology Drugs Revenue and Growth Rate (2013-2018)
7.3 Japan Rheumatology Drugs Revenue and Growth Rate (2013-2018)
7.4 Korea Rheumatology Drugs Revenue and Growth Rate (2013-2018)
7.5 India Rheumatology Drugs Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Rheumatology Drugs Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA RHEUMATOLOGY DRUGS REVENUE BY COUNTRIES

8.1 South America Rheumatology Drugs Revenue by Countries (2013-2018)
8.2 Brazil Rheumatology Drugs Revenue and Growth Rate (2013-2018)
8.3 Argentina Rheumatology Drugs Revenue and Growth Rate (2013-2018)
8.4 Colombia Rheumatology Drugs Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE RHEUMATOLOGY DRUGS BY COUNTRIES

9.1 Middle East and Africa Rheumatology Drugs Revenue by Countries (2013-2018)
9.2 Saudi Arabia Rheumatology Drugs Revenue and Growth Rate (2013-2018)
9.3 UAE Rheumatology Drugs Revenue and Growth Rate (2013-2018)
9.4 Egypt Rheumatology Drugs Revenue and Growth Rate (2013-2018)
9.5 Nigeria Rheumatology Drugs Revenue and Growth Rate (2013-2018)
9.6 South Africa Rheumatology Drugs Revenue and Growth Rate (2013-2018)

10 GLOBAL RHEUMATOLOGY DRUGS MARKET SEGMENT BY TYPE

10.1 Global Rheumatology Drugs Revenue and Market Share by Type (2013-2018)
10.2 Global Rheumatology Drugs Market Forecast by Type (2018-2023)
10.3 Disease Modifying Anti-rheumatic Drugs Revenue Growth Rate (2013-2023)
10.4 Nonsteroidal Anti-inflammatory Drugs Revenue Growth Rate (2013-2023)
10.5 Corticosteroids Revenue Growth Rate (2013-2023)
10.6 Uric Acid Drugs Revenue Growth Rate (2013-2023)
10.7 Others Revenue Growth Rate (2013-2023)

11 GLOBAL RHEUMATOLOGY DRUGS MARKET SEGMENT BY APPLICATION

11.1 Global Rheumatology Drugs Revenue Market Share by Application (2013-2018)
11.2 Rheumatology Drugs Market Forecast by Application (2018-2023)
11.3 Hospital Pharmacy Revenue Growth (2013-2018)
11.4 Retail Pharmacy Revenue Growth (2013-2018)
11.5 Online Pharmacy Revenue Growth (2013-2018)

12 GLOBAL RHEUMATOLOGY DRUGS MARKET SIZE FORECAST (2018-2023)

12.1 Global Rheumatology Drugs Market Size Forecast (2018-2023)
12.2 Global Rheumatology Drugs Market Forecast by Regions (2018-2023)
12.3 North America Rheumatology Drugs Revenue Market Forecast (2018-2023)
12.4 Europe Rheumatology Drugs Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Rheumatology Drugs Revenue Market Forecast (2018-2023)
12.6 South America Rheumatology Drugs Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Rheumatology Drugs Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Rheumatology Drugs Picture
Table Product Specifications of Rheumatology Drugs
Table Global Rheumatology Drugs and Revenue (Million USD) Market Split by Product Type
Figure Global Rheumatology Drugs Revenue Market Share by Types in 2017
Figure Disease Modifying Anti-rheumatic Drugs Picture
Figure Nonsteroidal Anti-inflammatory Drugs Picture
Figure Corticosteroids Picture
Figure Uric Acid Drugs Picture
Figure Others Picture
Table Global Rheumatology Drugs Revenue (Million USD) by Application (2013-2023)
Figure Rheumatology Drugs Revenue Market Share by Applications in 2017
Figure Hospital Pharmacy Picture
Figure Retail Pharmacy Picture
Figure Online Pharmacy Picture
Table Global Market Rheumatology Drugs Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Rheumatology Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Rheumatology Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Rheumatology Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Rheumatology Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Rheumatology Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Rheumatology Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Table Takeda Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Takeda Pharmaceutical Rheumatology Drugs Type and Applications
Table Takeda Pharmaceutical Rheumatology Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Rheumatology Drugs Type and Applications
Table Sanofi Rheumatology Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Genentech Basic Information, Manufacturing Base and Competitors
Table Genentech Rheumatology Drugs Type and Applications
Table Genentech Rheumatology Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Rheumatology Drugs Type and Applications
Table Novartis Rheumatology Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Janssen Biotech Basic Information, Manufacturing Base and Competitors
Table Janssen Biotech Rheumatology Drugs Type and Applications
Table Janssen Biotech Rheumatology Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Rheumatology Drugs Type and Applications
Table Amgen Rheumatology Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table AbbVie Basic Information, Manufacturing Base and Competitors
Table AbbVie Rheumatology Drugs Type and Applications
Table AbbVie Rheumatology Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Rheumatology Drugs Type and Applications
Table Pfizer Rheumatology Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Company Rheumatology Drugs Type and Applications
Table Bristol-Myers Squibb Company Rheumatology Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Merck & Co. Basic Information, Manufacturing Base and Competitors
Table Merck & Co. Rheumatology Drugs Type and Applications
Table Merck & Co. Rheumatology Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Global Rheumatology Drugs Revenue (Million USD) by Players (2013-2018)
Table Global Rheumatology Drugs Revenue Share by Players (2013-2018)
Figure Global Rheumatology Drugs Revenue Share by Players in 2016
Figure Global Rheumatology Drugs Revenue Share by Players in 2017
Figure Global Top 5 Players Rheumatology Drugs Revenue Market Share in 2017
Figure Global Top 10 Players Rheumatology Drugs Revenue Market Share in 2017
Figure Global Rheumatology Drugs Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Rheumatology Drugs Revenue (Million USD) by Regions (2013-2018)
Table Global Rheumatology Drugs Revenue Market Share by Regions (2013-2018)
Figure Global Rheumatology Drugs Revenue Market Share by Regions (2013-2018)
Figure Global Rheumatology Drugs Revenue Market Share by Regions in 2017
Figure North America Rheumatology Drugs Revenue and Growth Rate (2013-2018)
Figure Europe Rheumatology Drugs Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Rheumatology Drugs Revenue and Growth Rate (2013-2018)
Figure South America Rheumatology Drugs Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Rheumatology Drugs Revenue and Growth Rate (2013-2018)
Table North America Rheumatology Drugs Revenue by Countries (2013-2018)
Table North America Rheumatology Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Rheumatology Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Rheumatology Drugs Revenue Market Share by Countries in 2017
Figure USA Rheumatology Drugs Revenue and Growth Rate (2013-2018)
Figure Canada Rheumatology Drugs Revenue and Growth Rate (2013-2018)
Figure Mexico Rheumatology Drugs Revenue and Growth Rate (2013-2018)
Table Europe Rheumatology Drugs Revenue (Million USD) by Countries (2013-2018)
Figure Europe Rheumatology Drugs Revenue Market Share by Countries (2013-2018)
Figure Europe Rheumatology Drugs Revenue Market Share by Countries in 2017
Figure Germany Rheumatology Drugs Revenue and Growth Rate (2013-2018)
Figure UK Rheumatology Drugs Revenue and Growth Rate (2013-2018)
Figure France Rheumatology Drugs Revenue and Growth Rate (2013-2018)
Figure Russia Rheumatology Drugs Revenue and Growth Rate (2013-2018)
Figure Italy Rheumatology Drugs Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Rheumatology Drugs Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Rheumatology Drugs Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Rheumatology Drugs Revenue Market Share by Countries in 2017
Figure China Rheumatology Drugs Revenue and Growth Rate (2013-2018)
Figure Japan Rheumatology Drugs Revenue and Growth Rate (2013-2018)
Figure Korea Rheumatology Drugs Revenue and Growth Rate (2013-2018)
Figure India Rheumatology Drugs Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Rheumatology Drugs Revenue and Growth Rate (2013-2018)
Table South America Rheumatology Drugs Revenue by Countries (2013-2018)
Table South America Rheumatology Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Rheumatology Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Rheumatology Drugs Revenue Market Share by Countries in 2017
Figure Brazil Rheumatology Drugs Revenue and Growth Rate (2013-2018)
Figure Argentina Rheumatology Drugs Revenue and Growth Rate (2013-2018)
Figure Colombia Rheumatology Drugs Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Rheumatology Drugs Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Rheumatology Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Rheumatology Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Rheumatology Drugs Revenue Market Share by Countries in 2017
Figure Saudi Arabia Rheumatology Drugs Revenue and Growth Rate (2013-2018)
Figure UAE Rheumatology Drugs Revenue and Growth Rate (2013-2018)
Figure Egypt Rheumatology Drugs Revenue and Growth Rate (2013-2018)
Figure Nigeria Rheumatology Drugs Revenue and Growth Rate (2013-2018)
Figure South Africa Rheumatology Drugs Revenue and Growth Rate (2013-2018)
Table Global Rheumatology Drugs Revenue (Million USD) by Type (2013-2018)
Table Global Rheumatology Drugs Revenue Share by Type (2013-2018)
Figure Global Rheumatology Drugs Revenue Share by Type (2013-2018)
Figure Global Rheumatology Drugs Revenue Share by Type in 2017
Table Global Rheumatology Drugs Revenue Forecast by Type (2018-2023)
Figure Global Rheumatology Drugs Market Share Forecast by Type (2018-2023)
Figure Global Disease Modifying Anti-rheumatic Drugs Revenue Growth Rate (2013-2018)
Figure Global Nonsteroidal Anti-inflammatory Drugs Revenue Growth Rate (2013-2018)
Figure Global Corticosteroids Revenue Growth Rate (2013-2018)
Figure Global Uric Acid Drugs Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Table Global Rheumatology Drugs Revenue by Application (2013-2018)
Table Global Rheumatology Drugs Revenue Share by Application (2013-2018)
Figure Global Rheumatology Drugs Revenue Share by Application (2013-2018)
Figure Global Rheumatology Drugs Revenue Share by Application in 2017
Table Global Rheumatology Drugs Revenue Forecast by Application (2018-2023)
Figure Global Rheumatology Drugs Market Share Forecast by Application (2018-2023)
Figure Global Hospital Pharmacy Revenue Growth Rate (2013-2018)
Figure Global Retail Pharmacy Revenue Growth Rate (2013-2018)
Figure Global Online Pharmacy Revenue Growth Rate (2013-2018)
Figure Global Rheumatology Drugs Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Rheumatology Drugs Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Rheumatology Drugs Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Rheumatology Drugs Revenue Market Forecast (2018-2023)
Figure Europe Rheumatology Drugs Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Rheumatology Drugs Revenue Market Forecast (2018-2023)
Figure South America Rheumatology Drugs Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Rheumatology Drugs Revenue Market Forecast (2018-2023)